Retatrutide RETA 10mg (sema version 3)

Short Description: Triple agonist peptide (GIP/GLP-1/glucagon receptor) researched for metabolic regulation and body composition studies. Advanced research compound for weight management protocols.

Full Description: Retatrutide is a novel tri-agonist peptide that activates GIP, GLP-1, and glucagon receptors. Research applications focus on metabolic health, energy expenditure, appetite regulation, and body composition optimization studies. Represents next-generation peptide research in metabolic science, building upon dual-agonist compounds. Studied for its comprehensive approach to weight management and metabolic function.

Specifications:

• Purity: >99%
• Form: Lyophilized powder
• Molecular Weight: ~4.5 kDa
• Mechanism: GIP/GLP-1/Glucagon triple agonist
• Storage: 2-8°C refrigerated
• Reconstitution: Bacteriostatic water required
• Research grade compound
• Sealed sterile vial